Loading…
Loading…
TBG Dividend Focus ETF maintains a 'hold' rating due to balanced but unexceptional fundamentals versus peers like FDVV, DGRO, and SCHD. TBG's strategy targets capital appreciation, income, and income growth, but this balance plus the fund's strong diversification may dilute its ability to excel in any single area. Growth looks like a potential weakness. My analysis reveals next-year sales growth declining to 4.59% and EPS growth improving to 9.91%, while FDVV and DGRO are in the double digits.
WASHINGTON--(BUSINESS WIRE)--Best Medical International (BMI), a TeamBest Global (TBG) company, celebrates its 50th anniversary this year, marking five decades of innovation, technological advancement, and a commitment to improving clinical outcomes and saving lives. After losing his father to colon cancer in 1968, Dr. Krishnan Suthanthiran founded BMI and as President, has dedicated his career to advancing cancer care and developing technologies and initiatives designed to improve the lives of.
I prioritize dividend growth investing, building a core portfolio of select ETFs and high-quality individual stocks for stability and passive income. My approach favors continuity and flexibility, avoiding the risks of abrupt transitions from growth to dividend stocks near retirement. The portfolio centers on seven dividend growth ETFs, balancing moderate yield with robust growth potential and sector diversification.
TBG Dividend Focus ETF maintains a 'hold' rating as fundamentals remain competitive within its category. TBG offers a 12.75% next-year EPS growth rate, which should easily support future dividend growth, and a 3.59% estimated dividend yield that's well above its 2.70% trailing yield. The portfolio is concentrated but still well-diversified at the sector level, despite managers being sector agnostic. TBG's highest-weighted equity position is Blackstone at 4.55%.
Esco said that Megger, which provides testing, monitoring, and data solutions for utilities and infrastructure companies, would join its Utility Solution Group segment.
The TBG Dividend Focus ETF (TBG) earns a 'Hold' rating due to its elevated expense ratio and middling performance versus dividend ETF peers. TBG emphasizes dividend growth, valuation discipline, and low turnover, appealing to investors seeking stable, growing income and defensive positioning. The fund underperforms peers with higher technology exposure and lower fees, but offers a higher current SEC yield.
Dividend stocks have sharply outperformed AI-related tech stocks since November 2025, reversing a multi-year trend. I see the rally in dividend ETFs like SCHD as overextended, prompting a pause in new purchases despite recent gains. AI is likely to benefit users more than makers, with sectors like banks, energy, and consumer staples positioned as early winners.
TBG is an actively managed fund comprised of 30-40 U.S. stocks with solid track records of increasing dividends. Its expense ratio is 0.59%, and TBG's 30-day SEC yield is 3.26%. Despite its active mandate, TBG Dividend Focus ETF compares negatively to FDVV from a fundamentals perspective, offering meaningfully less growth and quality and only a marginally better yield. The fund's earnings growth rates may not be sufficient enough to sustain the 5-7% dividend growth targeted by management. Its 65.5% weighted payout ratio is arguably already stretched.
SEC filings for TBG aren't indexed yet (common for recently launched funds). Browse the issuer's filings on SEC EDGAR directly.